report the results of biliary bypass surgery in patients with pancreatic cancer. They pose the question whether a gastroenterostomy is necessary at the time of primary surgery. They note that 48 of 165 (29%) patients underwent a gastroenterostomy either to prevent gastric outlet obstruction or to treat it. They note a much higher mortality following biliary bypass with gastroenterostomy (10 of 37, 27%)compared with biliary bypass alone (18 of 128, 14%).
Unfortunately they have omitted to include several items of information that would help us to understand why the mortality was higher in patients with biliary bypass and gastroenterostomy.
Of 37 patients who had this combined procedure, seven were felt to have duodenal obstruction which required a bypass, and 30 were given gastroenterostomy prophylactically. The authors rightly point out that those with obstructing tumours could represent a group with larger, less favourable tumours, in whom the mortality might be higher. They do not tell us how many of the 10 deaths in the gastroenterostomy patients occurred in the seven patients with these less favourable tumours.
They also report that the choice of operation was related to the surgeon. Certain surgeons routinely carried out a gastroenterostomy in addition to a biliary bypass, whereas others adopted a more flexible approach. They do not tell us whether certain surgeons had a different operative mortality from others. It would also be of interest to know the grade of surgeon operating, and whether this influenced mortality.
Finally the type of biliary bypass may influence mortality", Very few patients in this series had bile duct anastomosis, but as their conclusions are based on the deaths of only 10 patients in the biliary bypass with gastroenterostomy group, it would be of interest to know the operative mortality in those patients who did have choledochojejunostomy or choledochoduodenostomy.
The authors argue that gastroenterostomy should not be done routinely at the time of biliary bypass because only 10% of patients will require this operation during follow-up after biliary bypass alone. It is my view that surgical palliation of pancreatic cancer offers an opportunity for permanent relief of symptoms (in contrast to endoscopic intubation, which may be followed by readmission for repeated changes of stent in patients who survive more than a few months 2 • 3 ) . In 648 cases reported by nine authors 1 there was no increased mortality in patients undergoing gastroenterostomy in addition to biliary bypass (17%)when compared to biliary bypass alone (18%), and I believe that this procedure should be a standard part of the initial surgical palliation in order to avoid the need for a second laparotomy in a significant number of patients. Holbrook et al: found this to be necessary in 10% of their patients undergoing biliary bypass alone, which is close to the 13% recorded in larger seriesl-', but reoperation rates up to 40%5 have been recorded.
The surgeon who is operating for palliation of pancreatic cancer may also relieve the symptom of pain by pancreatic duct drainage into the stomach or jejunum in patients with obstruction and dilatation of the duct or by celiac plexus ablation with alcohol injection". When operating for palliation of pancreatic cancer, the surgeon should take the opportunity to treat or prevent the symptoms of gastric outlet obstruction and pain, in addition to dealing with the obstructive jaundice. C D JOHNSON The author's reply
We enjoyed reading Mr Johnson's letter about our paper (January 1990 JRSM, p 12). The amount of information which can be gained from any retrospective survey is limited. There is no doubt however, that the most striking finding from our retrospective review of surgical palliation of pancreatic cancer was that minimal surgery is optimal for the victims of this horrid condition. The mean survival time after surgery was between 7 and 8 months. It seems sensible for the patients to spend as much of this time as possible out of hospital. Biliary bypass and pancreatic biopsy can be carried out without difficulty through a small subcostal incision. Recovery time is short, and the patients can soon be discharged back to their own environment. This sort of regimen has many of the advantages of endoscopic intubation, without the disadvantages of repeated admission for changes of the stent. It is humane and relatively free from risk. In British surgical practice there is no item of service payment based upon the complexity of the surgery. Many of the papers quoted by Johnson were from countries where an item of service is routine. This could produce a different pattern of surgical decision making from that found in Great Britain. Tokyo 160, Japan mention its effects on the incidence of cancer of the penis.
It was the late Sir Laurence Kennaway, FRS, who already in the 1940s, concluded his thorough studies into the incidence of cancer of the penis in relation to the time of circumcision: 'Cancer of the penis does not occur after circumcision on the eighth day accordingto the Jewish practice, but occurs in later life in Moslem populations,where the operation is carriedout between the 3rd and 14thyears ... Theprotection given by the Jewish operation is not due to removal of the cancer-bearing area. The influence of phimosis in predisposing to cancer of the penis suggests that the carcinogenic agent is formed in material between the prepuce and gland'I.
More recent epidemiological studies confirmed the striking protective action of newborn circumcision: the incidence of cancer of the penis in Uganda is 300 times higher than among the circumcised Jews, and in Connecticut (USA) is 10-fold higher than in Israel-, Detailed experimental studies are warranted into the 'material(s) formed between the prepuce and gland' -whether these may include some carcinogenic (and immunosuppressive) N-nitroso compounds, suggested to be involved in AIDS and in neoplasias related to AIDS3.4. Cardiac arrythmia and epilepsy Oppenheimer correctly states that some 'patients investigated for a cardiac arrhythmia are shown to have epilepsy' (April 1990 JRSM, p 134).The converse may also be true. He also reports that 'these patients responded well to anti-epileptlc medication' -it would be interesting to know which anti-epileptic drugs. I have recently seen a 15-year·old boy with a 3·year history of 'blackouts'. Electrocardiography had demonstrated Wolff-Parkinson-White syndrome but this was not recognized initially; electroencephalography had shown unstable and polyrhythmical features but no epileptiform discharges. He was diagnosed as having epilepsy and treated with phenytoin, with resolution of his symptoms. After 2 years the phenytoin was withdrawn gradually over 6 weeks. Within a week of discontinuing the drug he had two further 'blackouts', the second whilst swimming from which he suffered severe and irreversible neurological sequelae.
In retrospect it was felt that a cardiac dysrhythmia (supraventricular tachycardia) not epilepsy, was responsible for this boy's 'blackouts', with the response to phenytoin being due to its anti-arrhythmic and not anti-epileptic, action. RICHARD prospective study has clarified a correlation between non-steroidal anti-inflammatory drug (NSAID)therapy and nasal haemorrhage. Furthermore, they found that a significant proportion of patients with epistaxis had 'arthritis' when compared to the control group. We have not had an impression that the NSAIDs given to arthritic patients cause epistaxis when compared with gastrointestinal bleeding that is often induced by these drugs. Accordingly, our outpatients with arthritis were asked whether they had bled at the nose during the previous month. Of 102 patients (ie rheumatoid arthritis 82, systemic lupus erythematosus 5, osteoarthritis 4, others 11) examined, 79 have been taking NSAID (diclofenac 26, indomethacin 23, aspirin 10, piroxicam 4, others 16). Three rheumatoid arthritis patients had experienced epistaxis. Two patients, who have suffered from refractory epistaxis, have received aspirin, and the remaining one patient has taken no medicines. The existence of three cases of epistaxis may not be large enough to lead to a conclusion that NSAID or 'arthritis' is correlated with epistaxis, since it has been reported that some 3% in a population sample had nose-bleeds during the previous week'. However, we as well as other researchers-'' suspect that aspirin might predispose to epistaxis by interfering with a platelet function. On the other hand, Goldsweig et al. 4 had reviewed 14 cases of aspirin-induced hypoprothrombinaemic bleeding which was readily corrected with vitamin K.
Our investigation could not elucidate whether epistaxis correlates with either 'NSAID' or 'arthritis'. However, we agree entirely with the conviction that doctors and their patients should in future be warned of the possible risk of epistaxis before commencing NSAID, especially aspirin, treatment. Lastly, we look forward to the fruits of their study in progress to examine platelet function in some detail in patients taking NSAIDs who develop epistaxis. H AKAMA NHAMA K AMANO
